Article thumbnail

Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on Its Dopaminergic Effects

By Alice F. Viana, Izaque S. Maciel, Emerson M. Motta, Paulo C. Leal, Luiz Pianowski, Maria M. Campos and João B. Calixto


Trichilia catigua is a native plant of Brazil; its barks are used by some local pharmaceutical companies to prepare tonic drinks, such as Catuama. The present study was addressed to evaluate the effects of T. catigua hydroalcoholic extract in mouse nociception behavioral models, and to evaluate the possible mechanisms involved in its actions. Male Swiss mice were submitted to hot-plate, writhing and von Frey tests, after oral treatment with T. catigua extract (200 mg kg−1, p.o.). The extract displayed antinociceptive effect in all three models. For characterization of the mechanisms involved in the antinociceptive action of the extract, the following pharmacological treatments were done: naloxone (2.5 mg kg−1, s.c.), SR141716A (10 mg kg−1, i.p.), SCH23390 (15 μg kg−1, i.p.), sulpiride (50 mg kg−1, i.p.), prazosin (1 mg kg−1, i.p.), bicuculline (1 mg kg−1, i.p.) or dl-p-chlorophenylalanine methyl ester (PCPA, 100 mg kg−1, i.p.). In these experiments, the action of T. catigua extract was evaluated in the hot-plate test. The treatment with SCH23390 completely prevented the antinociceptive effect, while naloxone partially prevented it. The possible involvement of the dopaminergic system in the actions of T. catigua extract was substantiated by data showing the potentiation of apomorphine-induced hypothermia and by the prevention of haloperidol-induced catalepsy. In conclusion, the antinociceptive effects of T. catigua extract seem to be mainly associated with the activation of dopaminergic system and, to a lesser extent, through interaction with opioid pathway

Topics: Original Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). A .V i a n a ,J . - C .D oR e g o ,G .V o nP o s e re ta l . ,“ T h e antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamineuptake,”
  2. (1990). Acetorphan, an enkephalinase inhibitor, modulates dopaminergic transmission in rat olfactory tubercle, but not in the nucleus accumbens and striatum,”
  3. (1997). Analgesic effect of the herbal medicine Catuama in thermal and chemical models of nociception
  4. (2001). Animal models of nociception,”
  5. (1998). Antidepressant treatments in the 21st century,”
  6. (2005). Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms,”
  7. (2001). Antidepressants as analgesics: a review of randomized controlled trials,”
  8. (2003). Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum
  9. C h a p l a n ,F .W .B a c h ,J .W .P o g r e l ,J .M .C h u n g ,a n dT
  10. (2002). Descending control of pain,”
  11. (1997). eC a m p o s ,A .R .S .S a n t o s ,Z .R .V a ze ta l . , “Antinociceptive properties of the hydroalcoholic extract and preliminary study of a xanthone isolated from Polygala cyparissias
  12. (1999). Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity,”
  13. (1995). Effects of SCH 32615, an enkephalinase inhibitor,
  14. (1980). Efficient analysis of experimental observations,”
  15. (2008). Evaluation of the effects of the herbal product Catuama in inflammatory and neuropathic models of nociception in rats,”
  16. (2002). Geografic distribution and associated environments characterization of Trichilia catigua A. Juss.—Meliaceae in
  17. (1997). Herbal medicine Catuama induces endothelium-dependent and -independent vasorelaxant action on isolated vessels from rats, guinea-pigs and rabbits,”
  18. (2006). Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native toSouthBrazilwithantidepressant-likeactivity,”Fundamental and Clinical Pharmacology,
  19. (2004). Inhibition of platelet phospholipase A2 activity by catuaba extract suggests antiinflammatory properties,”
  20. (2008). J.StoneJr.,“Unexceptional seizure potential oftramadoloritsenantiomersormetabolitesinmice,”Journal of Pharmacology and
  21. (2001). K i n g ,S .B r a d s h a w ,A .H .C h a n g ,J .E .P i n t a r ,a n dG
  22. (2009). M e y e r ,M .M .M o r g a n ,L .B .K o z e l l ,a n dS .L .I n g r a m , “Contribution of dopamine receptors to periaqueductal graymediated antinociception,”
  23. (1997). M.L.Brand˜ ao,“Dores crˆ onicas,”in Neurobiologia das Doenc ¸as Mentais,F .G .G r a e ff
  24. (2006). Mesolimbicdopaminergic mechanisms and pain control,”
  25. (2003). Mic´ o, “Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites,”
  26. (2006). Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application,”
  27. (2001). n t u n e s ,W .M .G o r d o ,J .F .D eO l i v e i r a ,C .E .T e i x e i r a
  28. (2002). Nemeroff,R .D .B l a k e l ye ta l . , “Developing novel treatments for mood disorders: accelerating discovery,”
  29. (2007). o n t i e r i ,A .S .N e t o ,A .F .d eF r a n c ¸aCamargo,M.K.Koike, and
  30. (1991). o r g a na n dK .B .J .F r a n k l i n ,“ D o p a m i n er e c e p t o rs u b -types and formalintest analgesia,”Pharmacology
  31. (2004). Opiate anti-nociception is attenuated followinglesionoflargedopamineneuronsoftheperiaqueductal grey: critical role for
  32. (2004). otsch, “Morphine metabolites as novel analgesic drugs?”
  33. (2005). P e d e r s e n ,A .N .N i e l s e n ,a n dG .B l a c k b u r n - M u n r o , “Anti-nociception isselectivelyenhancedbyparallelinhibition ofmultiplesubtypes ofmonoaminetransporters inratmodels of persistent and neuropathic pain,” Psychopharmacology,v o l .
  34. (2004). Pharmacological and neurochemical evidence for antidepressant-like effects of the herbal product
  35. (1991). Pharmacological interaction of opiates with various classes of centrally acting dopaminergic drugs,”
  36. (2008). Role of central dopamine in pain and analgesia,”
  37. (1990). Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice,”
  38. (1981). Simon,“Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics,”
  39. (1964). Some narcotic antagonists in the Benzomorphan Series,”
  40. (1990). Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link,”
  41. (1998). The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways,”
  42. (1998). The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds,”
  43. (1999). The role of dopamine in the nucleus accumbens in analgesia,”